FDA Warning Letter — Morton Grove Pharmaceuticals, Inc.

Case 505993 — FEI 1420913

The FDA took a Warning Letter action against Morton Grove Pharmaceuticals, Inc. on Feb 17, 2017 (Morton Grove, IL). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action details

Facility
Morton Grove Pharmaceuticals, Inc.
Date
Feb 17, 2017
Fiscal Year
2017
Product Type
Drugs
Center
CDER
Location
Morton Grove, IL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.